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Notch is a key signaling protein mediating cell-fate decisions during development. In this issue, 
Acar et al. (2008) describe a new gene called rumi that is required for Notch signaling in Drosophila. 
This gene encodes an O-glucosyltransferase that attaches glucose sugars to serine residues in 
the multiple EGF domains of the extracellular region of Notch. This modification by Rumi likely 
influences Notch folding and trafficking.Notch proteins are receptors for a con-
served intercellular signaling pathway that 
mediates cell-fate decisions (Bray, 2006). 
Its diverse functions are reflected in the 
wide range of human diseases, including 
multiorgan congenital syndromes, can-
cers, and neurodegenerative diseases, 
associated with mutations in Notch path-
way components. Superficially, Notch 
signaling appears simple. Ligand-bound 
receptors are targeted for extracellular 
cleavage by a metalloprotease (the S2 
cleavage), and the product of the S2 cleav-
age is subject to intramembrane cleaveage 
by γ-secretase (the S3 cleavage). The S3 
cleavage liberates the Notch intracellu-
lar domain, which transits to the nucleus 
where it acts as a transcriptional activa-
tion domain. However, studies of Notch 
signaling have revealed complex layers of 
posttranslational regulation, involving pro-
teolytic processing, glycosylation, ubiquit-
ination, and endocytic trafficking.
In this issue, Acar et al. (2008) describe 
the discovery of a new gene required for 
Notch signaling in Drosophila, which they 
call rumi. Biochemical studies show that 
this gene encodes an enzyme, protein 
O-glucosyltransferase, that catalyzes a 
rare type of glycosylation event, which 
has only been found on epidermal growth 
factor-like (EGF) domains that include a 
particular sequence motif. O-Glucosy-
lation was first discovered on the blood 
clotting proteins Factors VII and IX (Hase 
et al., 1988) and subsequently was iden-
tified on Notch (Moloney et al., 2000). 
Its functional significance, however, 
remained unknown.
In their new work, Acar et al. (2008) 
identified rumi by a sensitive genetic 
screen involving the development of mechanosensory organs on the body of 
the fly (Acar et al., 2008). Mutations in the 
rumi gene cause a severe Notch pathway 
phenotype, and rumi may be universally 
required for Notch signaling in Drosophila. 
However, the severe phenotype of rumi 
mutants is only observed when flies are 
raised at elevated temperatures (28°C). 
Temperature sensitivity is often associ-
ated with missense mutations that influ-
ence the stability or folding of the affected 
protein, but the authors rule out this pos-
sibility by creating deletion alleles; these 
too are temperature sensitive. Thus, it 
appears that rumi affects the folding, 
conformation, or stability of Notch in a 
temperature-sensitive fashion.
Placing rumi within the Notch path-
way was acheived through a compelling 
series of genetic experiments (Acar et 
al., 2008). By examining genetic mosa-
ics, the authors established that rumi 
acts in signal-receiving cells and not in 
signal-sending cells. This is important 
because Notch ligands also contain 
EGF domains that could potentially be 
glycosylated by Rumi. Expression of a 
truncated form of Notch that is missing 
most of the extracellular domain (NECN) 
constitutively activates the expression 
of Notch target genes because this 
truncated protein mimics the product of 
the S2 cleavage. The activity of NECN is 
unaffected by mutations in rumi, which 
places the requirement for rumi some-
where upstream of S3 cleavage.
Rumi is a soluble protein of the endo-
plasmic reticulum (ER). This could 
be consistent with a requirement for 
O-glucosylation at later steps of Notch 
maturation or signaling. However, it also 
raises the possibility that Rumi might Cell 132participate in promoting the folding of 
Notch, either through an influence of gly-
cosylation on Notch folding or by acting 
directly as a chaperone. The possibility 
that Rumi might function as a chaperone 
is suggested by studies of another gly-
cosyltransferase, O-fucosyltransferase 1 
(Ofut1). Like Rumi, Ofut1 is an ER protein 
that catalyzes a rare type of glycosyla-
tion on EGF domains and has a broad 
role in Notch signaling (Haines and Irvine, 
2003). This was initially taken to reflect a 
universal requirement for O-fucose mod-
ification of Notch for Notch signaling. 
However it was subsequently realized 
that, at least in Drosophila, Ofut1 acts as 
a Notch chaperone, facilitating the fold-
ing and secretion of Notch (Okajima et 
al., 2005). The fucosyltransferase activity 
of Ofut1 is not required to promote Notch 
folding. Indeed, rescue experiments with 
Ofut1 isoforms that lack fucosyltrans-
ferase activity but retain chaperone 
activity have revealed that in some con-
texts Notch does not need to be O-fuco-
sylated (Okajima et al., 2008). Acar et al. 
conducted similar experiments with rumi 
but found that point mutations that elimi-
nate or reduce its O-glucosyltransferase 
activity impair the function of Rumi in 
Notch signaling.
If the glucosyltransferase activity of 
rumi is truly essential, then mutation 
of genes required for the synthesis of 
UDP-glucose (the universal sugar donor 
for glucosyltransferases), or of genes 
required for UDP-glucose transport 
into the ER, should result in equivalent 
Notch pathway phenotypes. Intriguingly, 
such mutations may already exist. Sev-
eral years ago, a gene encoding a UDP-
sugar transporter called fringe connec-, January 25, 2008 ©2008 Elsevier Inc. 177
tion (frc) was identified (Goto 
et al., 2001; Selva et al., 2001). 
Most of the phenotypes of 
frc can be explained by its 
role in transporting UDP-N-
Acetylglucosamine (UDP-
GlcNAc). However, a fraction 
of embryos lacking frc dis-
play a classic Notch neuro-
genic phenotype, and Notch 
processing defects can be 
observed in frc mutants (Goto 
et al., 2001). Although these 
phenotypes were puzzling at 
the time, given that frc may 
also transport UDP-glucose 
and UDP-xylose (Goto et al., 
2001; Selva et al., 2001), they 
might now be explained by 
a requirement for O-glucose 
glycans for correct function 
of Notch.
An O-fucosylated EGF domain 
is a substrate for another gly-
cosyltransferase, Fringe, which 
attaches GlcNAc to O-fucose 
and thereby modulates Notch 
signaling in certain contexts 
(Haines and Irvine, 2003). Nota-
bly, the O-glucose added by 
Rumi also creates a substrate 
for additional glycosyltrans-
ferases. Studies of the blood 
clotting factor, Factor IX, iden-
tified a trisaccharide on its EGF 
domain, Xyl-Xyl-Glc (Hase et 
al., 1988), and mammalian 
Notch1 is also modified by a trisaccharide 
form of O-glucose (Moloney et al., 2000). 
The responsible xylosyltransferases have 
not been cloned, but the functional Rumi-
dependent glycan on Notch might not be 
an O-glucose monosaccharide but rather 
a di- or trisaccharide. It will also be interest-
ing to determine the expression patterns 
of both Rumi and the xylosyltransferases, 
as it is not yet clear whether they act as 
ubiquitous cofactors for Notch matura-
tion or whether their expression might be 
temporally or spatially modulated in some 
contexts to influence Notch signaling.
Even though Notch is misfolded in the 
absence of Ofut1, it accumulates to high 
levels inside cells—presumably because 
Notch normally turns over very rapidly. A 
similar accumulation of Notch inside cells 
is observed in the absence of rumi. How-
ever, in rumi mutants, Notch is also found at 
its normal cell-surface location and indeed 
appears elevated there (Acar et al., 2008), 
whereas Notch is not detectable at its nor-
mal cell-surface location in Ofut1 mutants 
(Okajima et al., 2005, 2008; Sasamura et 
al., 2007). This might suggest that Notch 
trafficks normally to the cell surface in the 
absence of rumi. However, trafficking of 
membrane proteins is a dynamic process. 
For example, exocytosis of Notch to the 
plasma membrane might be only 5% of 
its normal rate, but if endocytosis of Notch 
is reduced to a similar or greater extent, 
Notch levels at the surface could appear 
normal or elevated. Thus far we have 
mostly static pictures of what happens 
to Notch in the absence of rumi or Ofut1. 
A fuller understanding of the trafficking 
defects in these mutants will require both 
more dynamic approaches and better 
markers for subdomains of the secretory 
pathway. At present, the sim-
plest explanation is that in both 
mutants a significant fraction 
of Notch is misfolded, and this 
misfolded protein is retained 
in the ER and/or subsequent 
secretory  compartments.
Given that Notch reaches the 
cell surface in rumi mutants, 
why is signaling impaired? 
Loss of ligand binding is not 
likely the cause because Notch 
binding to the Delta ligand 
was unaffected by RNAi-
mediated reduction of rumi 
in a cell-based assay (Acar 
et al., 2008). This finding sug-
gests that O-glucosylation is 
required for the conformational 
changes of Notch that occur 
subsequent to ligand binding, 
which make Notch a substrate 
for the S2 cleavage. The ability 
to separate ligand binding from 
ligand-dependent processing 
may provide a valuable tool 
for future investigation. It also 
contrasts with the misfolded 
Notch isolated from Ofut1-de-
pleted cells, which is defective 
in ligand binding (Haines and 
Irvine, 2003). Nonetheless, it 
is possible that the influences 
of Ofut1 and Rumi on Notch 
are fundamentally similar: they 
might both influence the ter-
tiary conformation of Notch 
by associating with and modifying EGF 
domains (Figure 1). Many Notch proteins 
contain 36 EGF domains, one-half to two-
thirds of which typically contain consen-
sus sites for modification by Ofut1 or Rumi 
(Haines and Irvine, 2003). Notably, the 
distribution of their respective consensus 
sites differs. Thus, the distinct phenotypes 
of Ofut1 and rumi might really be telling us 
something about the distinct roles of dif-
ferent EGF domains in Notch. Structural 
studies, and comparisons among Notch 
receptors with different distributions of 
O-fucose and O-glucose sites, may ulti-
mately help to clarify this.
It seems remarkable that Notch has such 
an extensive requirement for recognition of 
its EGF domains by glycosyltransferases 
in the ER. In Drosophila Notch, only 5 of its 
36 domains are devoid of both O-fucose 
and O-glucose sites (Haines and Irvine, 
Figure 1. Glycosylation Sites in the Notch Extracellular Domain
(A) The extracellular domain of Drosophila Notch has 36 EGF domains (ovals) 
and three Lin12-Notch repeats (pentagons); recognition sites for the glycosyl-
transferases Ofut1 (blue) and Rumi (yellow) are depicted. 
(B) A hypothetical structure of the Notch extracellular domain in wild-type 
flies (top). EGF domains recognized by both Rumi and Ofut1 are in green. 
In the absence of Rumi, Notch might be partially misfolded in a way that is 
temperature sensitive and allows ligand binding but precludes subsequent 
processing (middle). In the absence of Ofut1, Notch might be misfolded in 
a different way, precluding cell-surface expression and ligand binding at all 
temperatures (bottom).178 Cell 132, January 25, 2008 ©2008 Elsevier Inc.
2003; Moloney et al., 2000). Moreover, 
there are other proteins with multiple EGF 
domains, but Notch appears to be unique 
in its functional requirement for Ofut1 and 
rumi. Once the structural basis for their 
influence is determined, the logic behind 
this may become clear. For now, the dis-
covery of the rumi O-glucosyltransferase 
is another sweet success from studies of 
Notch signaling in the fly.
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HHMI for support.Signaling by the cytokines interleukin-4 
(IL-4) and interleukin-13 (IL-13) is criti-
cal for T cell development and T cell-
mediated immune responses, including 
allergy. IL-4 and IL-13 signal through a 
heterotrimeric complex consisting of the 
cytokine and two receptors. The recep-
tor complexes for IL-4 come in two vari-
eties, type I and type II. Type I receptor 
complexes comprise the IL-4Rα and 
γ-chain (γc) subunits. The presence of the 
γc subunit defines type I complexes and 
γc is present in receptor complexes for at 
least six different cytokines (Kelly-Welch 
et al., 2003). The type II receptor for IL-4 
is a complex of IL-4Rα and IL-13Rα1, 
which also serves as a receptor for IL-13. 
However, despite signaling through the 
same type II receptor, IL-4 and IL-13 ini-
tiate distinct signaling responses even 
in the same cell types. In this issue, 
LaPorte et al. (2008) present crystal 
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receptor molecule, forming the ligand-
receptor interface I (Figure 1A). In the 
second step, another receptor molecule 
binds to the ligand through the interface 
site II. Only a few other crystal structures 
before or since have had such an impact 
and explained as much.
With the availability of the hGH/GHR 
structure, as well as crystal structures of 
free cytokines (Rozwarski et al., 1994), a 
plethora of models of other complexes 
have been generated, including that of 
IL-4 with its receptors (Gustchina et al., 
1995). Although these models explain at 
least some of the signaling properties 
correctly, subsequent crystal structures, 
including a binary complex of IL-4 and 
IL-4α (Hage et al., 1999), have shown 
them to be oversimplified. In addition, 
understanding the close structural and 
biological relationships between differ-
ent cytokines, such as IL-4 and IL-13, has 
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